J. V. Vande Voort

发表

Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review

Allison C. Nugent, Carlos A. Zarate, E. Ballard, 2015, Therapeutic advances in chronic disease.

An Exploratory Study of Spectroscopic Glutamatergic Correlates of Cortical Excitability in Depressed Adolescents

M. Frye, M. Husain, J. Port, 2016, Front. Neural Circuits.

Cortical inhibitory and excitatory correlates of depression severity in children and adolescents.

M. Husain, Z. Daskalakis, S. Ameis, 2016, Journal of affective disorders.

Deiodinase variation and liothyronine treatment interaction to accelerate ECT response in major depression: Pilot data and implications for thyroid pharmacogenomic testing in mood disorders

M. Frye, T. Rummans, J. Biernacka, 2021, Personalized Medicine in Psychiatry.

Family functioning and maternal distress in adolescent girls with anorexia nervosa.

K. Schak, J. V. Vande Voort, A. Lteif, 2009, The International journal of eating disorders.

Medical Comorbidity of Attention-Deficit/Hyperactivity Disorder in US Adolescents

K. Merikangas, Jian-ping He, J. V. Vande Voort, 2016, Journal of child neurology.

Recurrent Isolated Sleep Paralysis Following Bupropion Cessation: A Case Report.

J. V. Vande Voort, B. Kolla, A. McKean, 2019, Journal of clinical psychopharmacology.

Benchmarking and Optimizing Pharmacologic Restraint for Agitated Youth in the Emergency Medicine Department.

J. V. Vande Voort, P. Croarkin, 2021, The Journal of pediatrics.

The Role of Parental Capacity for Medical Decision-Making in Medical Ethics and the Care of Psychiatrically Ill Youth: Case Report

J. V. Vande Voort, A. McKean, Julia Shekunov, 2020, Frontiers in Psychiatry.

A case of a four-year-old child adopted at eight months with unusual mood patterns and significant polypharmacy

J. V. Vande Voort, A. McKean, M. Romanowicz, 2017, BMC Psychiatry.

The Association Between Body Mass Index and Remission Rates in Patients With Treatment-Resistant Depression Who Received Intravenous Ketamine.

Cynthia J. Stoppel, M. Frye, J. Biernacka, 2019, The Journal of clinical psychiatry.

Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression

E. Ballard, D. Luckenbaugh, D. Ionescu, 2015, Neural plasticity.

Acute risk factors for suicide attempts and death: prospective findings from the STEP‐BD study

E. Ballard, D. Luckenbaugh, C. Zarate, 2016, Bipolar disorders.

Potential Risks of Poorly Monitored Ketamine Use in Depression Treatment.

Emily K. Johnson, Brian A Palmer, M. Frye, 2016, The American journal of psychiatry.

Sequential bilateral accelerated theta burst stimulation in adolescents with suicidal ideation associated with major depressive disorder: Protocol for a randomized controlled trial

P. Nakonezny, J. V. Vande Voort, J. Leffler, 2022, medRxiv.

A Retrospective Multicenter Evaluation of Clozapine Use in Pediatric Patients Admitted for Acute Psychiatric Hospitalization.

K. Schak, J. V. Vande Voort, J. Leung, 2018, Journal of child and adolescent psychopharmacology.

Rehospitalization to a child and adolescent psychiatry unit: Role of trauma and bullying.

K. Schak, J. V. Vande Voort, A. McKean, 2018, General hospital psychiatry.

Cortical inhibitory markers of lifetime suicidal behavior in depressed adolescents

G. Worrell, H. Jo, J. Port, 2018, Neuropsychopharmacology.

Treatments and Services Provided to Children Diagnosed with Bipolar Disorder

P. Jensen, C. Wall, K. Schak, 2016, Child psychiatry and human development.

Treatments and Services Provided to Children Diagnosed with Bipolar Disorder

P. Jensen, C. Wall, K. Schak, 2015, Child Psychiatry & Human Development.

Impact of the DSM-5 attention-deficit/hyperactivity disorder age-of-onset criterion in the US adolescent population.

K. Merikangas, Jian-ping He, J. V. Vande Voort, 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

Symptom trajectories in the months before and after a suicide attempt in individuals with bipolar disorder: A STEP‐BD study

K. Merikangas, E. Ballard, C. Zarate, 2019, Bipolar Disorders.

The PHQ-9 Item 9 based screening for suicide risk: a validation study of the Patient Health Questionnaire (PHQ)-9 Item 9 with the Columbia Suicide Severity Rating Scale (C-SSRS).

P. Zandi, W. Bobo, F. Goes, 2018, Journal of affective disorders.

The effects of parental opioid use on the parent–child relationship and children’s developmental and behavioral outcomes: a systematic review of published reports

T. Rummans, K. Schak, J. V. Vande Voort, 2019, Child and Adolescent Psychiatry and Mental Health.

Psychometric Properties of the Patient Health Questionnaire-9 Modified for Major Depressive Disorder in Adolescents.

P. Nakonezny, J. V. Vande Voort, P. Croarkin, 2019, Journal of child and adolescent psychopharmacology.

Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder.

E. Ballard, D. Luckenbaugh, C. Zarate, 2017, The Journal of clinical psychiatry.

Nocturnal Wakefulness Is Associated With Next-Day Suicidal Ideation in Major Depressive Disorder and Bipolar Disorder.

M. Furey, E. Ballard, D. Luckenbaugh, 2016, The Journal of clinical psychiatry.

Ketamine’s Antidepressant Efficacy is Extended for at Least Four Weeks in Subjects with a Family History of an Alcohol Use Disorder

M. Furey, E. Ballard, D. Luckenbaugh, 2014, The international journal of neuropsychopharmacology.

An Update on the Efficacy and Tolerability of Oral Ketamine for Major Depression: A Systematic Review and Meta-Analysis.

M. Frye, K. Schak, J. V. Vande Voort, 2020, Psychopharmacology bulletin.

Human Leukocyte Antigen Genetics and Clinical Features of Self-treated Patients on a Gluten-free Diet

Tsung-Teh Wu, J. Murray, J. V. Vande Voort, 2013, Journal of clinical gastroenterology.

Immune mediated pediatric encephalitis – need for comprehensive evaluation and consensus guidelines

J. V. Vande Voort, J. Tillema, P. Croarkin, 2020, BMC Neurology.

Evidence for machine learning guided early prediction of acute outcomes in the treatment of depressed children and adolescents with antidepressants

M. Trivedi, A. Athreya, R. Weinshilboum, 2022, Journal of child psychology and psychiatry, and allied disciplines.

Lack of Rating Scale Normalization and a Socioeconomically Advantaged Population Limits the Generalizability of Preadolescent Transgender Findings

J. V. Vande Voort, A. McKean, P. Croarkin, 2016, Pediatrics.

Patients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depression.

F. Goes, S. Parikh, J. V. Vande Voort, 2022, Journal of affective disorders.

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

M. Furey, E. Ballard, D. Luckenbaugh, 2014, Journal of psychiatric research.

Efficacy and safety of lamotrigine in pediatric mood disorders: A systematic review

A. Athreya, J. V. Vande Voort, P. Croarkin, 2022, Acta psychiatrica Scandinavica.

Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta‐analysis of randomized controlled trials

M. Frye, S. McElroy, J. Biernacka, 2020, Bipolar disorders.

KETAMINE FOR TREATMENT‐RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE

M. Frye, W. Bobo, S. Tye, 2016, Depression and anxiety.

Baseline Vitamin B12 and Folate Levels Do Not Predict Improvement in Depression After a Single Infusion of Ketamine

D. Luckenbaugh, D. Ionescu, C. Zarate, 2014, Pharmacopsychiatry.

A Systematic Review of Long-Interval Intracortical Inhibition as a Biomarker in Neuropsychiatric Disorders

F. Farzan, J. V. Vande Voort, P. Croarkin, 2021, Frontiers in Psychiatry.

A Randomized Controlled Trial of Combinatorial Pharmacogenetics Testing in Adolescent Depression.

M. Frye, J. V. Vande Voort, J. Geske, 2021, Journal of the American Academy of Child and Adolescent Psychiatry.

Long-Interval Intracortical Inhibition and the Cortical Silent Period in Youth

J. V. Vande Voort, P. Croarkin, Can Ozger, 2023, Biomedicines.

Can ketamine be a safe option for treatment-resistant bipolar depression?

M. Frye, J. V. Vande Voort, Balwinder Singh, 2022, Expert opinion on drug safety.

Hypomania associated with high dose ketamine treatment

M. Frye, W. McDonald, P. Riva-Posse, 2021, Bipolar disorders.

Continuation phase intravenous ketamine in adults with treatment-resistant depression.

Brian A Palmer, M. Frye, R. Morgan, 2016, Journal of affective disorders.

Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.

E. Ballard, D. Luckenbaugh, C. Zarate, 2015, Journal of psychiatric research.

Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications

R. Alarcón, M. Frye, J. Biernacka, 2019, Front. Pharmacol..

Clinical and Genetic Correlates of Bipolar Disorder With Childhood-Onset Attention Deficit Disorder

M. Frye, S. McElroy, J. Biernacka, 2022, Frontiers in Psychiatry.

Early reduction in irritability is associated with improved outcomes among youth with depression: Findings from the AMOD study.

J. V. Vande Voort, M. Jha, P. Croarkin, 2022, Journal of affective disorders.

Effects of Parental Opioid Use: Outcomes of Children of Parents in Medication-Assisted Treatment Compared to Healthy Controls.

T. Rummans, J. V. Vande Voort, P. Croarkin, 2019, The Primary Care Companion For CNS Disorders.

Riluzole likely lacks antidepressant efficacy in ketamine non-responders.

M. Furey, E. Ballard, D. Luckenbaugh, 2014, Journal of psychiatric research.

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

D. Luckenbaugh, D. Ionescu, C. Zarate, 2014, The Journal of clinical psychiatry.

Lymphocytic Duodenosis and the Spectrum of Celiac Disease

Tsung-Teh Wu, J. Murray, J. V. Vande Voort, 2009, The American Journal of Gastroenterology.

Increased fear-potentiated startle in major depressive disorder patients with lifetime history of suicide attempt.

C. Grillon, E. Ballard, D. Ionescu, 2014, Journal of affective disorders.

Medical students speak: A two‐voice comment on learning professionalism in medicine

J. V. Vande Voort, Esther H Krych, 2006, Clinical anatomy.

Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report

Emily K. Johnson, K. Schak, J. V. Vande Voort, 2023, Pharmaceuticals.

Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study.

M. Frye, P. Schulte, K. Schak, 2023, The Journal of clinical psychiatry.

Ketamine-Associated Change in Anhedonia and mTOR Expression in Treatment-Resistant Depression

M. Frye, P. Riva-Posse, S. Tye, 2023, Biological Psychiatry.

J. V. Vande Voort, P. Croarkin, Charles P. Lewis, 2023, The international journal of neuropsychopharmacology.

The PHQ-9 Item 9 based screening for suicide risk: a validation study of the Patient Health Questionnaire (PHQ)-9 Item 9 with the Columbia Suicide Severity Rating Scale (C-SSRS).

W. Bobo, F. Goes, J. V. Vande Voort, 2018, Journal of Affective Disorders.

Treatment resistant patients with baseline suicidal ideation required more treatments to achieve therapeutic response with ketamine/esketamine.

J. V. Vande Voort, M. A. Frye, Balwinder Singh, 2024, Journal of affective disorders.

High Probability of Gene-Drug Interactions Associated with Medication Side Effects in Adolescent Depression: Results from a Randomized Controlled Trial of Pharmacogenetic Testing.

J. V. Vande Voort, Julia Shekunov, M. Romanowicz, 2024, Journal of child and adolescent psychopharmacology.

National network of depression centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder.

M. Niciu, J. V. Vande Voort, D. Feifel, 2023, Journal of affective disorders.

Machine Learning Identifies Smartwatch-Based Physiological Biomarker for Predicting Disruptive Behavior in Children: A Feasibility Study

M. Skime, J. V. Vande Voort, P. Croarkin, 2023, Journal of child and adolescent psychopharmacology.

The Use of Ketamine for the Treatment of Anhedonia in Depression.

J. V. Vande Voort, Balwinder Singh, Liliana Patarroyo-Rodriguez, 2024, CNS drugs.

Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression.

Cynthia J. Stoppel, W. Bobo, S. Tye, 2023, Journal of affective disorders.